Matsakaicin Halitta CAS 57280-22-5
  • Matsakaicin Halitta CAS 57280-22-5 Matsakaicin Halitta CAS 57280-22-5

Matsakaicin Halitta CAS 57280-22-5

Mai zuwa shine gabatarwar madaidaicin Organic Intermediate CAS 57280-22-5.
4,4-Dimethyl-3,5,8-trioxabic-yclo[5,1,0] Octane CAS 57280-22-5 aiki
2-methoxyethylamine ana amfani dashi azaman reagent don shirya lipid kamar kayan don isar da magunguna na RNAi.

Aika tambaya

Bayanin Samfura

Believe Chemical ƙwararren jagora ne na China Organic Intermediate CAS 57280-22-5 masana'anta tare da babban inganci da farashi mai ma'ana. Yi imani Chemical ƙwararren ƙwararren masani ne na China Organic Intermediate CAS 57280-22-5 masana'anta kuma mai siyarwa, idan kuna neman mafi kyawun Matsakaicin Matsakaicin CAS 57280-22-5 tare da ƙarancin farashi, tuntuɓar mu yanzu! Shandong Amince


4,4-Dimethyl-3,5,8-trioxabic-yclo[5,1,0] Bayanin Sinadarai na Octane

Sunan samfur

4,4-Dimethyl-3,5,8-trioxabic-yclo[5,1,0] Octane

Formula

Nauyin Kwayoyin Halitta

75.11

CAS NO.

57280-22-5

Yawan

500KG


Abubuwa

Ƙayyadaddun bayanai

Sakamako

Bayyanar

Share ruwa

Ya dace

Assay

â¥99.0%

99.10%

Indexididdigar refractive

1.4560

KAMMALAWA

Sakamakon ya dace da ma'auni


4,4-Dimethyl-3,5,8-trioxabic-yclo[5,1,0]Octane Chemical Properties


Sunan samfur

CAS NO.

Tsarin kwayoyin halitta

EINECS

MW

Yawan yawa

Wurin tafasa

Rayuwar rayuwa

Yanayin ajiya

Misali


4,4-Dimethyl-3,5,8-trioxabic-yclo[5,1,0]Octane Chemical

4,4-dimethyl-3,5,8-dioxabicyclo [5,1,0] octane shine maɓalli mai mahimmanci a cikin shirye-shiryen gadolinium butoxide.



Zafafan Tags: Organic Intermediate CAS 57280-22-5, Masu masana'antu, Masu Bayar da kayayyaki, Kasuwanci, Masana'antu, A cikin Hannun jari, An yi a China, China, Rahusa, Rangwame, Inganci, API, Bincike da haɓakawa, Haɗin kai

Rukunin da ke da alaƙa

Aika tambaya

Da fatan za a ji daɗin ba da tambayar ku a cikin fom ɗin da ke ƙasa. Za mu ba ku amsa a cikin sa'o'i 24.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept